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Osteoporosis is one of the major diseases that affects the aging population with enormous cost in morbidity and mortality to the subject and to the community in demands on the provision of care. The growing financial costs are becoming increasingly apparent in a cost conscious health care service. There were 43 230 hip fractures in England in 1985,' and average hospital inpatient stay was 30 days. Excess mortality in the subsequent 12 months is up to 20%,2 and survivors often have permanent disability and dependency-50% no longer walking independently. 3 The hospital costs of these fractures were estimated at £160 million in 1987-8,4 but this omits the costs of community care. It also ignores the indirect cost in suffering to these patients on long waiting lists for joint replacement surgery that has been delayed because orthopaedic resources cannot deal adequately with both them and the unpredictable workload of trauma. The morbidity of vertebral fractures is not always so obvious. Loss of height and stoop has long been dismissed as normal aging. It is true that it is common in the elderly-22-5% of 70 year old women having a vertebral fracture,5-but it should not be considered inevitable or of no consequence as it does produce symptoms, is preventable,6 and is treatable. 7 Despite this high prevalence collagen degradation as it may also arise from the collagens of skin and soft tissue; it may also arise from the breakdown of procollagen peptides released during collagen synthesis. The sensitivity of this marker is further reduced by the ability of the liver to metabolise up to 90% of the plasma pool. Recently, much work has centred on the use of pyridinium cross links of collagen in the study of metabolic and inflammatory bone disease, and there is now sufficient evidence to indicate that these components, especially the cross links specific to bone collagen (deoxypyridinoline), are more specific and more sensitive markers of bone degradation than those used previously.'9 20 Long term studies are needed to assess whether these measurements on a single occasion will predict change in bone mass over a period of time.
Histomorphometry of iliac crest bone biopsy specimens is used to assess the structural changes that accompany age related bone loss. Trabecular bone loss may result from trabecular thinning with overall trabecular architecture preserved or there may be erosion through and removal of trabeculae leading to a much greater loss of connectedness of the bone structural pattern.2' Loss ofthe connectedness is associated with greater reduction in bone strength than trabecular thinning,22 and although thinning may be reversible,23 it is unknown whether trabecular connectedness can be restored. There is a cycle of bone cell activity with osteoclasts initially resorbing bone followed by osteoblasts depositing osteoid, which is subsequently calcified and mineralised. Any imbalance of this cycle will result in net bone loss.24 These processes can be assessed by histomorphometry with double tetracycline labelling giving dynamic indices of formation and can be used to study differences between patients with and without fracture, between different types of osteoporosis, and to monitor the response to treatment. Disadvantages are that it is invasive, time consuming, and normal variation can be great, making the method unsuitable for routine assessment.
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